DUBLIN , June 3, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the Goldman Sachs 42 nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 10:30 a.m. ET ( 3:30 p.m. BST ). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
About Alkermes plc
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com .
Contact:
Alex Braun
Investor Relations
+1 781 296 8493
View original content to download multimedia: http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-goldman-sachs-annual-global-healthcare-conference-301305712.html
SOURCE Alkermes plc
